Vyome(HIND.US)

Last Updated 19:00:00 ET
longbridge loading

Vyome | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 31.59 K

Earnings Watch·
US
HIND
+1.90%
Earnings Watch·
US
HIND
+1.90%

Vyome | 10-K: FY2025 Revenue Beats Estimate at USD 319.71 K

Earnings Watch·
US
HIND
+1.90%
Earnings Watch·
US
HIND
+1.90%

Vyome Therapeutics: Undervalued Buy on De-Risked VT-1953 Program and Pivotal Phase 3 Catalyst in a >$2B Orphan Market

Tip Ranks·
US
HIND
+1.90%
US
IBB
+0.17%
US
PBE
-0.28%
Tip Ranks·
US
HIND
+1.90%
US
IBB
+0.17%
US
PBE
-0.28%

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga_article·
US
IXJ
+0.21%
US
XBI
+0.09%
US
IHI
-1.50%
benzinga_article·
US
IXJ
+0.21%
US
XBI
+0.09%
US
IHI
-1.50%

Cullen Investment Group LTD. Has $744,000 Holdings in Edwards Lifesciences Corporation $EW

Market Beat·
US
HIND
+1.90%
US
FBT
+0.14%
US
LABU
+0.17%
Market Beat·
US
HIND
+1.90%
US
FBT
+0.14%
US
LABU
+0.17%

Sentynl and PRG partner for Progerinin licence

Pharmaceutical Technology·
US
SBIO
+0.62%
US
ZYXIQ
0.00%
US
BBH
+0.32%
Pharmaceutical Technology·
US
SBIO
+0.62%
US
ZYXIQ
0.00%
US
BBH
+0.32%

Supriya Lifescience Publishes Postal Ballot Notice in Newspapers

Tip Ranks·
US
RSLS
0.00%
US
LABU
+0.17%
US
XBI
+0.09%
Tip Ranks·
US
RSLS
0.00%
US
LABU
+0.17%
US
XBI
+0.09%

Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics

Tip Ranks·
US
HIND
+1.90%
US
VYNE
+0.27%
Tip Ranks·
US
HIND
+1.90%
US
VYNE
+0.27%
© 2026 Longbridge｜Disclaimer